Exabis Library
Welcome to the e-CCO Library!
DOP09 IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapy-naive Crohn’s disease patients with increased microbiota-specific T-cell reactivity
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP090: Risk factors for bacteraemia in hospitalised patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP090: Risk factors for bacteremia in hospitalized patients with Inflammatory Bowel Disease
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP090: The α7 nicotinic acetylcholine receptor agonist GTS-21 attenuate DSS-induced colitis by improving intestinal mucosal barrier function
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP090: The Role of The Microbiome in Clinical Response to Golimumab in Ulcerative Colitis
2016
ECCO'16 DOP
1
DOP090: The role of the microbiome in clinical response to golimumab in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP090: The α7 nicotinic acetylcholine receptor agonist GTS-21 attenuate DSS-induced Colitis by improving intestinal mucosal barrier function
2017
ECCO'17 Barcelona
1
DOP09: Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP09: Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP09: Interleukin-20 subfamily cytokines in controlling intestinal inflammation and epithelial barrier integrity
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP09: Mirikizumab-induced transcriptome changes in patient biopsies at Week 12 are maintained through Week 52 in patients with Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP09: Models for predicting Crohn Disease (CD) exacerbation using serum and fecal metabolomics
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP09: Phenotypic and genetic determinants of medication response in patients in the UK IBD BioResource
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP10 Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP10: Early intestinal resection in Crohn's Disease is not associated with severe long-term disease course
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP10: Early intestinal resection in Crohn’s Disease is not associated with severe long-term disease course
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP10: Intestinal Ultrasound at IBD diagnosis predicts major disease events – A Copenhagen IBD cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP10: Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s Disease: Week 16 interim analysis of the STARDUST trial substudy
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP10: Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s Disease: Week 16 interim analysis of the STARDUST trial substudy
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP10: Persistent sonographic Inflammation as a predictor of clinical complications in patients with Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM